TP53 and neoplasm: The TP53 deficiency can facilitate the occurrence of genetic alterations and thus enlarges the pool of tumor cells that have the potential to be selected out to become CRPC, possibly through mechanisms such as direct promotion of genome instability and/or protecting cells from genomic stress/exogenous cytotoxicity agents.